Your browser doesn't support javascript.
loading
The European/International Fibromuscular Dysplasia Registry and Initiative (FEIRI)-clinical phenotypes and their predictors based on a cohort of 1000 patients.
Pappaccogli, Marco; Di Monaco, Silvia; Warchol-Celinska, Ewa; Lorthioir, Aurélien; Amar, Laurence; Aparicio, Lucas S; Beauloye, Christophe; Bruno, Rosa Maria; Chenu, Patrick; de Leeuw, Peter; De Backer, Tine; Delmotte, Philippe; Dika, Zivka; Gordin, Daniel; Heuten, Hilde; Iwashima, Yoshio; Krzesinski, Jean-Marie; Kroon, Abraham A; Mazzolai, Lucia; Poch, Esteban; Sarafidis, Pantelis; Seinturier, Christophe; Spiering, Wilko; Toubiana, Laurent; Van der Niepen, Patricia; van Twist, Daan; Visonà, Adriana; Wautrecht, Jean-Claude; Witowicz, Helena; Xu, Jianzhong; Prejbisz, Aleksander; Januszewicz, Andrzej; Azizi, Michel; Persu, Alexandre.
Afiliação
  • Pappaccogli M; Division of Internal Medicine and Hypertension Unit, Department of Medical Sciences, University of Turin, Turin, Italy.
  • Di Monaco S; Division of Cardiology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, 10 Avenue Hippocrate, 1200 Brussels, Belgium.
  • Warchol-Celinska E; Pole of Cardiovascular Research, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, 1200 Brussels, Belgium.
  • Lorthioir A; Division of Internal Medicine and Hypertension Unit, Department of Medical Sciences, University of Turin, Turin, Italy.
  • Amar L; Department of Hypertension, National Institute of Cardiology, Warsaw, Poland.
  • Aparicio LS; Hypertension Unit and DMU CARTE, AP-HP, Hôpital Européen Georges Pompidou, Paris, France.
  • Beauloye C; Hypertension Unit and DMU CARTE, AP-HP, Hôpital Européen Georges Pompidou, Paris, France.
  • Bruno RM; Université de Paris, CIC1418, INSERM, Paris, France.
  • Chenu P; Hypertension Section, Internal Medicine Department, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
  • de Leeuw P; Division of Cardiology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, 10 Avenue Hippocrate, 1200 Brussels, Belgium.
  • De Backer T; Pole of Cardiovascular Research, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, 1200 Brussels, Belgium.
  • Delmotte P; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
  • Dika Z; INSERM U970 and Université de Paris, Paris, France.
  • Gordin D; Division of Cardiology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, 10 Avenue Hippocrate, 1200 Brussels, Belgium.
  • Heuten H; Pole of Cardiovascular Research, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, 1200 Brussels, Belgium.
  • Iwashima Y; Department of Medicine, Maastricht University Medical Center, Maastricht, The Netherlands.
  • Krzesinski JM; Department of Cardiovascular Diseases, University Hospital Ghent, Ghent, Belgium.
  • Kroon AA; Hypertension Excellence Centre, Department of Cardiology, Ambroise Paré University Hospital, Mons, Belgium.
  • Mazzolai L; Department of Nephrology, Arterial Hypertension, Dialysis and Transplantation, University Hospital Center Zagreb, School of Medicine University of Zagreb, Zagreb, Croatia.
  • Poch E; Helsinki Hypertension Centre of Excellence, University of Helsinki, Helsinki University Hospital, Helsinki, Finland.
  • Sarafidis P; Abdominal Center Nephrology, University of Helsinki, Helsinki University Hospital, Helsinki, Finland.
  • Seinturier C; Folkhälsan Institute of Genetics, Folkhälsan Research Centre, Biomedicum Helsinki, Helsinki, Finland.
  • Spiering W; Department of Cardiology, University Hospital of Antwerp, Edegem, Belgium.
  • Toubiana L; Department of Nephrology and Hypertension, Dokkyo Medical University, Tochigi, Japan.
  • Van der Niepen P; Division of Nephrology, Department of Internal Medicine, University of Liège Hospital, Liège, Belgium.
  • van Twist D; Groupe Interdisciplinaire de Génoprotéomique Appliquée (GIGA), Cardiovascular Sciences, University of Liège, Liège, Belgium.
  • Visonà A; Department of Medicine, Maastricht University Medical Center, Maastricht, The Netherlands.
  • Wautrecht JC; Division of Angiology, Heart and Vessel Department, Lausanne University Hospital-CHUV, Centre of Rare Vascular Diseases and RAVAD Registry, Lausanne, Switzerland.
  • Witowicz H; Department of Nephrology and Kidney Transplantation, Hospital Clínic of Barcelona, Institut D'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.
  • Xu J; Department of Nephrology, Hippokration Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.
  • Prejbisz A; Department of Cardiovascular Disease, Competence Center for Rare Vascular Diseases, European Center of Excellence in Arterial Hypertension, Grenoble-Alpes University Hospital, CS Grenoble Cedex 9, France.
  • Januszewicz A; Department of Vascular Medicine, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
  • Azizi M; Sorbonne Université, Université Paris 13, Sorbonne Paris Cité, INSERM, UMR_S1142, LIMICS, IRSAN, Paris, France.
  • Persu A; Department of Nephrology & Hypertension, Universitair Ziekenhuis Brussel , Vrije Universiteit Brussel (VUB), Brussels, Belgium.
Cardiovasc Res ; 117(3): 950-959, 2021 02 22.
Article em En | MEDLINE | ID: mdl-32282921
ABSTRACT

AIMS:

Since December 2015, the European/International Fibromuscular Dysplasia (FMD) Registry enrolled 1022 patients from 22 countries. We present their characteristics according to disease subtype, age and gender, as well as predictors of widespread disease, aneurysms and dissections. METHODS AND

RESULTS:

All patients diagnosed with FMD (string-of-beads or focal stenosis in at least one vascular bed) based on computed tomography angiography, magnetic resonance angiography, and/or catheter-based angiography were eligible. Patients were predominantly women (82%) and Caucasians (88%). Age at diagnosis was 46 ± 16 years (12% ≥65 years old), 86% were hypertensive, 72% had multifocal, and 57% multivessel FMD. Compared to patients with multifocal FMD, patients with focal FMD were younger, more often men, had less often multivessel FMD but more revascularizations. Compared to women with FMD, men were younger, had more often focal FMD and arterial dissections. Compared to younger patients with FMD, patients ≥65 years old had more often multifocal FMD, lower estimated glomerular filtration rate and more atherosclerotic lesions. Independent predictors of multivessel FMD were age at FMD diagnosis, stroke, multifocal subtype, presence of aneurysm or dissection, and family history of FMD. Predictors of aneurysms were multivessel and multifocal FMD. Predictors of dissections were age at FMD diagnosis, male gender, stroke, and multivessel FMD.

CONCLUSIONS:

The European/International FMD Registry allowed large-scale characterization of distinct profiles of patients with FMD and, more importantly, identification of a unique set of independent predictors of widespread disease, aneurysms and dissections, paving the way for targeted screening, management, and follow-up of FMD.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Displasia Fibromuscular / Dissecção Aórtica Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Displasia Fibromuscular / Dissecção Aórtica Idioma: En Ano de publicação: 2021 Tipo de documento: Article